Morgan Stanley
-
-
-
-
-
-
-
Myriad Genetics to Present at the 2019 Morgan Stanley Global Healthcare Conference
-
-
-
-
-
-
-
Myriad Genetics (MYGN) PT Raised to $49 at Morgan Stanley
-
-
-
-
-
-
-
Myriad Genetics (MYGN) PT Raised to $26 at Morgan Stanley
-
-
-
-
-
-
-
Maverick Capital's 13F Shows New Stakes in Computer Sciences (CSC), Level 3 (LVLT), Philip Morris (PM), Increase in Comcast (CMCSA), Gilead (GILD) (More...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 11/10: (NFX) (BDBD) (PHM) Upgraded; (GNW) (ANF) (GWW) Downgraded
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 12/30: (ELMD) (BORN) (SEV) Higher; (CANF) (WPCS) (VISN) Lower
-
-
-
-
-
-
-
David Moenning's Daily State of the Markets: 7/1
-
158,370 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All